Literature DB >> 15704173

Familial risks for colorectal cancer show evidence on recessive inheritance.

Kari Hemminki1, Bowang Chen.   

Abstract

Recent molecular genetic data have become available on a recessive inheritance in colorectal cancer (CRC). We wanted to search for evidence for recessive inheritance from a population-based family data set, which is not sensitive to reporting or ascertainment bias. The nationwide Swedish Family-Cancer Database covered 10.3 million individuals whose invasive CRCs of adenocarcinoma histology were followed from 1991 to 2000. Age of the offspring and parental populations was limited to less than 69 years. Standardized incidence ratios (SIRs) were calculated for site-specific CRC in offspring whose parents or siblings were diagnosed with CRC. A total of 6,774 offspring were recorded with CRC, whose risk was 2.13 when a parent was diagnosed with CRC and it was 2.75 when a sibling was affected. The SIRs for right-sided colon cancer were 7.53 among siblings and 3.66 among offspring of affected parents, giving a 1.8-fold excess familial risk among siblings. Colon cancer among the 0- to 68-year-old population accounted for about 25% of all colon cancers. Examination of all cancers in family members of the affected siblings did not reveal large contribution by known syndromes, such as hereditary nonpolyposis colorectal cancer. The most likely explanation to the high risk of right-sided colon cancer among siblings is a recessive inheritance, which would account for 0.75% of all CRCs. Its high prevalence and predilection to right-sided colon suggest that only a small proportion of this familial aggregation could be due to MYH mutations. (c) 2005 Wiley-Liss, Inc.

Entities:  

Mesh:

Year:  2005        PMID: 15704173     DOI: 10.1002/ijc.20938

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  7 in total

Review 1.  Serrated pathway colorectal cancer in the population: genetic consideration.

Authors:  Joanne Young; Mark Jenkins; Susan Parry; Bruce Young; Derek Nancarrow; Dallas English; Graham Giles; Jeremy Jass
Journal:  Gut       Date:  2007-06-12       Impact factor: 23.059

Review 2.  Evidenced-Based Screening Strategies for a Positive Family History.

Authors:  Jennifer M Kolb; Dennis J Ahnen; N Jewel Samadder
Journal:  Gastrointest Endosc Clin N Am       Date:  2020-04-14

3.  Colorectal cancer risks in relatives of young-onset cases: is risk the same across all first-degree relatives?

Authors:  Lisa A Boardman; Bruce W Morlan; Kari G Rabe; Gloria M Petersen; Noralane M Lindor; Sandra K Nigon; Julia Goldberg; Steven Gallinger
Journal:  Clin Gastroenterol Hepatol       Date:  2007-08-16       Impact factor: 11.382

Review 4.  Understanding the contribution of family history to colorectal cancer risk and its clinical implications: A state-of-the-science review.

Authors:  Jan T Lowery; Dennis J Ahnen; Paul C Schroy; Heather Hampel; Nancy Baxter; C Richard Boland; Randall W Burt; Lynn Butterly; Megan Doerr; Mary Doroshenk; W Gregory Feero; Nora Henrikson; Uri Ladabaum; David Lieberman; Elizabeth G McFarland; Susan K Peterson; Martha Raymond; N Jewel Samadder; Sapna Syngal; Thomas K Weber; Ann G Zauber; Robert Smith
Journal:  Cancer       Date:  2016-06-03       Impact factor: 6.860

5.  Meta-analyses of colorectal cancer risk factors.

Authors:  Constance M Johnson; Caimiao Wei; Joe E Ensor; Derek J Smolenski; Christopher I Amos; Bernard Levin; Donald A Berry
Journal:  Cancer Causes Control       Date:  2013-04-06       Impact factor: 2.506

6.  Polymorphisms in the mitochondrial oxidative phosphorylation chain genes as prognostic markers for colorectal cancer.

Authors:  Jesus Lascorz; Melanie Bevier; Witigo V Schönfels; Holger Kalthoff; Heiko Aselmann; Jan Beckmann; Jan Egberts; Stephan Buch; Thomas Becker; Stefan Schreiber; Jochen Hampe; Kari Hemminki; Asta Försti; Clemens Schafmayer
Journal:  BMC Med Genet       Date:  2012-04-30       Impact factor: 2.103

7.  Genetic association studies of alterations in protein function expose recessive effects on cancer predisposition.

Authors:  Nadav Brandes; Nathan Linial; Michal Linial
Journal:  Sci Rep       Date:  2021-07-21       Impact factor: 4.379

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.